BioCentury | Mar 30, 2018
Company News

Therapure Biopharma spins out Evolve Biologics

...of Therapure along with rights to plasma products and technology in China. At that time, Therapure's...
...8, 2017 ). Therapure Biopharma's remaining IP includes its protein-drug conjugation and half-life extension technologies. Therapure Biopharma Inc....
...Mississauga, Ontario Business: Biomanufacturing Shannon Lehnbeuter IV-Globulin SN Inj (Brand), IVIG-SN (Informal), IV-Globulin SN inj (Informal) Evolve Biologics Inc. Therapure Biopharma Inc. Albumin...
BioCentury | Sep 8, 2017
Company News

3SBio to acquire Therapure's CDMO business

...the private equity arm of CITIC, will acquire the contract development and manufacturing business of Therapure Biopharma Inc....
...to innovation. The company is developing antibodies and biologics in nephrology, oncology and autoimmune indications. Therapure's...
...close this year. Therapure Biopharma Inc. , Mississauga, Ontario 3SBio Inc. (HKSE:1530), Shenyang, China Business: Biomanufacturing Alicia Parker 3SBio Inc. Therapure Biopharma Inc....
BioCentury | Sep 5, 2017
Company News

3SBio to acquire Therapure's CDMO business

...the private equity arm of CITIC, will acquire the contract development and manufacturing business of Therapure Biopharma Inc....
...to innovation. The company is developing antibodies and biologics in nephrology, oncology and autoimmune indications. Therapure's...
...of its holdings in the JV to 3SBio after four years. The JV will retain Therapure’s...
BioCentury | Jan 4, 2016
Finance

Curbed enthusiasm

...Up to $86.3M IND Cancer Prevention Pharmaceuticals Inc. (NYSE) 12/23/15 Up to $30.1M Ph III Therapure Biopharma Inc....
BioCentury | Dec 7, 2015
Financial News

Therapure proposes IPO

...raised: TBD Shares: TBD Price: TBD Underwriters: GMP Securities; CIBC World Markets; National Bank Note: Therapure...
BioCentury | Nov 14, 2011
Company News

Antitope, Therapure deal

...Antitope and Therapure partnered to develop humanized therapeutic mAbs for several indications using Antitope's Composite Human...
...using Antitope's Composite Human Antibody technology. Terms were not disclosed. Antitope Ltd. , Babraham, U.K. Therapure Biopharma Inc....
Items per page:
1 - 6 of 6
BioCentury | Mar 30, 2018
Company News

Therapure Biopharma spins out Evolve Biologics

...of Therapure along with rights to plasma products and technology in China. At that time, Therapure's...
...8, 2017 ). Therapure Biopharma's remaining IP includes its protein-drug conjugation and half-life extension technologies. Therapure Biopharma Inc....
...Mississauga, Ontario Business: Biomanufacturing Shannon Lehnbeuter IV-Globulin SN Inj (Brand), IVIG-SN (Informal), IV-Globulin SN inj (Informal) Evolve Biologics Inc. Therapure Biopharma Inc. Albumin...
BioCentury | Sep 8, 2017
Company News

3SBio to acquire Therapure's CDMO business

...the private equity arm of CITIC, will acquire the contract development and manufacturing business of Therapure Biopharma Inc....
...to innovation. The company is developing antibodies and biologics in nephrology, oncology and autoimmune indications. Therapure's...
...close this year. Therapure Biopharma Inc. , Mississauga, Ontario 3SBio Inc. (HKSE:1530), Shenyang, China Business: Biomanufacturing Alicia Parker 3SBio Inc. Therapure Biopharma Inc....
BioCentury | Sep 5, 2017
Company News

3SBio to acquire Therapure's CDMO business

...the private equity arm of CITIC, will acquire the contract development and manufacturing business of Therapure Biopharma Inc....
...to innovation. The company is developing antibodies and biologics in nephrology, oncology and autoimmune indications. Therapure's...
...of its holdings in the JV to 3SBio after four years. The JV will retain Therapure’s...
BioCentury | Jan 4, 2016
Finance

Curbed enthusiasm

...Up to $86.3M IND Cancer Prevention Pharmaceuticals Inc. (NYSE) 12/23/15 Up to $30.1M Ph III Therapure Biopharma Inc....
BioCentury | Dec 7, 2015
Financial News

Therapure proposes IPO

...raised: TBD Shares: TBD Price: TBD Underwriters: GMP Securities; CIBC World Markets; National Bank Note: Therapure...
BioCentury | Nov 14, 2011
Company News

Antitope, Therapure deal

...Antitope and Therapure partnered to develop humanized therapeutic mAbs for several indications using Antitope's Composite Human...
...using Antitope's Composite Human Antibody technology. Terms were not disclosed. Antitope Ltd. , Babraham, U.K. Therapure Biopharma Inc....
Items per page:
1 - 6 of 6